What is Parkinson's Phase 3 Study CoQ10 QE3?

Category: Others

false

See also: Clinical Trial

NCT00740714 is a a clinical trial of the effects of Coenzyme Q10 with vitamin E in Parkinson Disease. Other study IDs includes: U01NS050324, QE3.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Parkinson's Phase 3 Study CoQ10 QE3

Side effect Patients

Why patients stopped taking Parkinson's Phase 3 Study CoQ10 QE3

Multiple reasons could be selected

Reason Patients
Other 1
See all 1 patient who’ve stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration

Stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration Patients
1 - 2 years 1
Adherence
Adherence Evaluations
Always 0
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Parkinson's Phase 3 Study CoQ10 QE3.